We are proud to announce that Donna Gruol,
(XGen DJB’s own Vice President of Business Development)
was Elected to the Executive Committee:
DCAT Board of Directors, as Third Vice President.
XGen Pharmaceuticals DJB, Inc. is closely monitoring the status of the COVID-19 outbreak and its impact locally and globally.
We are committed to keeping our employees and business partners safe.
We are implementing our Crisis Management Plan, and we have a Business Continuity Plan to sustain operations should a quarantine or lockdown situation be put into effect.
As part of our Crisis Management Plan, we are doing the following:
- Adhering to health and safety standards
- Postponing non-essential travel
- Educating employees on recommended practices to reduce the spread of all viruses
- Planning for remote work for essential functions
- Working with suppliers and customers to minimize any impact to the supply chain
We will continue to monitor the situation and comply with all mandatory and recommended actions, and communicate to our business partners, as appropriate.
If you have any specific questions, please send them to PMO@xgenpharmadjb.com